Yale Medicine School Researchers Identify Gene That Worsens Fatty Liver Disease
December 08, 2021
December 08, 2021
NEW HAVEN, Connecticut, Dec. 8 (TNSJou) -- Yale School of Medicine issued the following news:
Nonalcoholic fatty liver disease (NAFLD) affects almost a quarter of adults worldwide. Yale researchers have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. The study appears in the December 2 issue of the Journal of Clinical Investigation.
Mutations in the gene Dyrk1b have been associated wi . . .
Nonalcoholic fatty liver disease (NAFLD) affects almost a quarter of adults worldwide. Yale researchers have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. The study appears in the December 2 issue of the Journal of Clinical Investigation.
Mutations in the gene Dyrk1b have been associated wi . . .